Cargando…
Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia–Reperfusion Injury
In recent years, cell membrane drug delivery systems have received increasing attention. However, drug-loaded membrane delivery systems targeting therapy in myocardial ischemia–reperfusion injury (MIRI) have been relatively rarely studied. The purpose of this study was to explore the protective effe...
Autores principales: | Zhou, Tingting, Yang, Xuechao, Wang, Tianyi, Xu, Mingming, Huang, Zhanghao, Yu, Runze, Jiang, Yi, Zhou, Youlang, Shi, Jiahai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227294/ https://www.ncbi.nlm.nih.gov/pubmed/35736311 http://dx.doi.org/10.3390/membranes12060605 |
Ejemplares similares
-
Platelet membrane-camouflaged nanoparticles carry microRNA inhibitor against myocardial ischaemia‒reperfusion injury
por: Wang, Tianyi, et al.
Publicado: (2022) -
Effects of Carvedilol on liver ischemia-reperfusion injury in rats
por: Tolga Kafadar, Mehmet, et al.
Publicado: (2022) -
Platelets in Myocardial Ischemia/Reperfusion Injury
por: Schanze, Nancy, et al.
Publicado: (2022) -
Nrf2 Promotes Inflammation in Early Myocardial Ischemia-Reperfusion via Recruitment and Activation of Macrophages
por: Zhang, Haijian, et al.
Publicado: (2021) -
Platelet Membrane–Encapsulated MSNs Loaded with SS31 Peptide Alleviate Myocardial Ischemia-Reperfusion Injury
por: Zhang, Zaiyuan, et al.
Publicado: (2022)